01st November 2021 | Pharma Updates
India's pharma industry should address climate change challenges: Principal Scientific Adviser
Indian pharma industry should address challenges of climate change, biodiversity and environmental impacts, said K Vijay Raghavan, Principal Scientific Adviser to the GoI.
Jammu & Kashmir Price Monitoring & Resource Unit Conducts Webinar On Availability Of Safe Drugs
The Price Monitoring & Resource Unit, J&K hosted a webinar as a part of a celebration of Azadi ka Amrit Mahotsav.
India reports 12830 fresh Covid cases, 446 deaths
India’s total tally of Covid cases reached 34273300, while the active Covid cases declined to 159272.
Global tablet shipments fell 10% as vendors face supply challenges
Global tablet shipments fell 10% YoY in the 3rd quarter as vendors face supply chain challenges.
Public-private partnership built in fight against Covid can strengthen healthcare system: Dr. Naresh Trehan
Strong public-private partnership built during the country’s collective fight against Covid, can go a long way in strengthening India’s healthcare system, says Naresh Trehan, chairman and chief cardiac surgeon, Medanta–The MediCity.
Role of policymakers to address TB
Policymakers play an important role in changing the attitudes of persons as they are respected within the community and are considered reliable sources of information from the officials.
Drug shortage puts haemophilia patients at risk
Haemophilia is a genetic disorder that slows down the body’s ability to make blood clots, a process necessary to stop bleeding.